NAHSV Healthlinko Private Limited today highlighted strong operating momentum as it completed its first year, driven by patient growth, revenue performance, profitable operations and expanding international partnerships through its flagship healthcare platform, MediFyr.
Founded in April 2025, the company was launched with the objective of improving access to healthcare through technology-led solutions that simplify patient discovery, coordination and support. One year later, the company says its early performance reflects growing demand for its model and validates the opportunity ahead.
At the center of that progress has been MediFyr, which currently supports more than 2,000 patients each month across a range of medical needs. According to the company, increasing patient trust and growing demand have contributed to meaningful business traction, including ₹65 lakh in revenue generated in the last quarter of the previous financial year.
NAHSV Healthlinko said the growth is particularly significant because it has been achieved without external investment, with the business operating as a profitable and bootstrapped company throughout its foundational year.
Management noted that this approach has allowed the company to prioritize sustainable expansion, operational discipline and long-term value creation while maintaining flexibility for future growth.
Alongside the growth of MediFyr, the company has continued developing complementary brands including Zerunio, WhatPregnant, HealthSetu and Unikorn, supporting a broader strategy focused on building a diversified digital health ecosystem.
As it enters year two, the company said expanding beyond India will be a major strategic focus. Through MediFyr, the company has already developed hospital partnerships across Turkey, Egypt, Israel, Thailand, UAE and China, laying the groundwork for broader participation in cross-border healthcare and international patient facilitation.
The company said these partnerships provide an initial international foundation from which it intends to expand MediFyr’s global presence further over the coming year.
“Our first year has been about establishing credibility, proving the model and creating a strong operating base,” the company said in a statement. “The opportunity now is to build on that foundation and scale responsibly across new markets.”
Looking ahead, NAHSV Healthlinko said it remains focused on expanding patient reach, strengthening technology infrastructure, growing strategic partnerships and increasing market presence across both domestic and international channels.
With profitable performance, early international relationships and growing traction through MediFyr, the company believes it is entering its second year positioned for sustained growth.
This press release is provided by a third party. The website does not verify its accuracy and is not responsible for its content or any resulting claims.
